Testing effectiveness (Phase 2)Active Not RecruitingNCT03366844What this trial is testingBreast Cancer Study of Preoperative Pembrolizumab + RadiationWho this might be right forBreast Cancer Stephen Shiao 66
Large-scale testing (Phase 3)Looking for participantsNCT04601116What this trial is testingThe MASTER Study (MAmmary Cancer STatin ER Positive Study)Who this might be right forBreast Cancer FemaleEstrogen Receptor Positive Tumor Aarhus University Hospital 3,360
Testing effectiveness (Phase 2)Active Not RecruitingNCT01992952What this trial is testingFulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast CancerWho this might be right forEstrogen Receptor Positive Breast Cancer Velindre NHS Trust 149
Early research (Phase 1)Active Not RecruitingNCT06533059What this trial is testingLearn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid TumorsWho this might be right forCancerBreast CancerEndometrial Cancer+2 more Alterome Therapeutics, Inc. 110
Not applicableLooking for participantsNCT06127979What this trial is testingChanges in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before SurgeryWho this might be right forBreast Cancer Memorial Sloan Kettering Cancer Center 42
Testing effectiveness (Phase 2)Looking for participantsNCT06452394What this trial is testingNEODOXy: Targeting Breast Cancer Stem Cells With DoxycyclineWho this might be right forBreast Cancer Swiss Cancer Institute 50
Testing effectiveness (Phase 2)Study completedNCT00057941What this trial is testingAnastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast CancerWho this might be right forEstrogen Receptor-positive Breast CancerProgesterone Receptor-positive Breast CancerRecurrent Breast Cancer+1 more National Cancer Institute (NCI) 148
Large-scale testing (Phase 3)UnknownNCT01104571What this trial is testingTrastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast CancerWho this might be right forBreast Cancer Institute of Cancer Research, United Kingdom 257
Testing effectiveness (Phase 2)Looking for participantsNCT06062498What this trial is testingElacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast CancerWho this might be right forEstrogen-receptor-positive Breast CancerHER2/Neu-Negative Breast CancerAdvanced Breast Cancerv+1 more Northwestern University 174
Early research (Phase 1)Study completedNCT03554044What this trial is testingT-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+11 more University of California, San Francisco 20
Testing effectiveness (Phase 2)WithdrawnNCT02115594What this trial is testingPhase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast CancerWho this might be right forBreast Cancer Syndax Pharmaceuticals
Early research (Phase 1)Study completedNCT01770353What this trial is testingMM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to TreatmentWho this might be right forSolid TumorsER/PR Positive Breast CancerTriple Negative Breast Cancer+1 more Ipsen 45
Not applicableUnknownNCT05613270What this trial is testingCharacterizing Breast Cancer With 18F-FES PET/CTWho this might be right forBreast Cancer Peking Union Medical College Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT04965688What this trial is testingBiology Guided Therapy for Breast Cancer for ER PositiveWho this might be right forBreast CancerEstrogen Receptor-positive Breast CancerHER2-negative Breast Cancer Inova Health Care Services 2
Large-scale testing (Phase 3)Study completedNCT00785291What this trial is testingPaclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast CancerWho this might be right forEstrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+6 more National Cancer Institute (NCI) 799
Testing effectiveness (Phase 2)WithdrawnNCT01612910What this trial is testingOral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and SurgeryWho this might be right forBreast Cancer Female Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT07616453What this trial is testingEfficacy and Safety of Culmerciclib Plus Aromatase Inhibitors in a Response-Adapted Neoadjuvant Strategy for Highly Proliferative ER-Positive/HER2-Negative Breast CancerWho this might be right forHR+/HER2- Early Breast Cancer Second Affiliated Hospital, Zhejiang University, School of Medicine 45
Testing effectiveness (Phase 2)Ended earlyNCT02269670What this trial is testingPhase II Study of Everolimus Beyond ProgressionWho this might be right forEstrogen Receptor-positive Breast CancerHER2-negative Breast CancerProgesterone Receptor-positive Breast Cancer+5 more Emory University 3
Not applicableLooking for participantsNCT06805812What this trial is testingPredicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 StudyWho this might be right forBreast AdenocarcinomaBreast Cancer Stage IVBreast Cancer, Metastatic+38 more Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 3,500
Testing effectiveness (Phase 2)Study completedNCT02536742What this trial is testingPalbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer ETOP IBCSG Partners Foundation 124